Cancer Institute

The complexities inherent in the diagnosis, management, and treatment of hematological cancers require the full spectrum of care. The Cancer Institute offers the best care for cancer patients throughout all phases of their complex disease with hematological malignancies including:

• Leukemia
  • Acute Myelogenous Leukemia (AML)
  • Chronic Myelogenous Leukemia (CML)
  • Acute Lymphocytic Leukemia (ALL)
  • Chronic Lymphocytic Leukemia (CLL)
• Lymphoproliferative Disorders
• Lymphoma
  • Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma (NHL)
• Myelodysplastic Syndrome (MDS)
• Myeloproliferative Disorders
• Multiple Myeloma (MM)
• Waldenstrom's Macroglobulinemia

The Cancer Institute is a nationally recognized provider of advanced treatment programs for patients with blood related disorders and was one of just 35 centers nationwide to be recognized as a Center of Excellence by the Myelodysplastic Syndromes Foundation in 2001.

We offer a multi-disciplinary approach with state-of-the-art services including clinical trials, educational resources, community support, social services as well as specialists in stem cell transplant, hemostasis and thrombosis oncologists, pathologists, medical oncologists, radiation oncologists and oncology nurses. 

The team participates in a variety of oncological services including cutting-edge treatment options and specialized nursing care for symptom management. New treatment approaches and drug therapies are available to help improve patients' responses to chemotherapy, stimulate the patient's immune system, and promote the manufacturing of normal blood cells. 

We are committed to providing personalized, one-on-one care and supporting not only the physical needs of the patient, but the emotional needs as well. The goal is to minimize patient discomfort and emphasize a better quality of life.

Learn more about Hematology in our Health Library.